Cleared Traditional

K070311 - CARDIOBLATE GEMINI SURGICAL ABLATION DE...

K070311 is the FDA 510(k) clearance for CARDIOBLATE GEMINI SURGICAL ABLATION DE... by Medtronic Vascular. It is a Class 2 General & Plastic Surgery device (product code GEI) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K070311 · Medtronic Vascular · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
82d
Days
Class 2
Risk

K070311 is an FDA 510(k) clearance for the CARDIOBLATE GEMINI SURGICAL ABLATION DEVICE, MODELS 49260 AND 49261. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Medtronic Vascular (Brooklyn Park, US). The FDA issued a Cleared decision on April 24, 2007 after a review of 82 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular devices

Submission Details

510(k) Number K070311 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2007
Decision Date April 24, 2007
Days to Decision 82 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 115d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1185
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K070311.
STRYKER RF INTRADISCAL ADAPTOR, MODEL 406-750
K063480 · Stryker Corp. · May 2007
ARTHROCARE CAVITY SPINEWAND
K063172 · Arthrocare Corp. · Apr 2007
ARTHROCARE ENT PLASMA WAND
K070374 · Arthrocare Corp. · Apr 2007
MODIFICATION TO ARTHROCARE ARTHROWANDS
K070958 · Arthrocare Corp. · Apr 2007
ARTHROCARE SPINEWANDS
K070851 · Arthrocare Corp. · Apr 2007
MODIFICATION TO AUTOCON II 400 ELECTROSURGICAL GENERATOR
K062464 · KARL STORZ Endoscopy-America, Inc. · Feb 2007

Related FDA 510(k) Regulatory Insights

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.